Fludarabine Phosphate
Product manufactured by Areva Pharmaceuticals
Indications and Purposes
1 Indications And Usage Fludarabine Phosphate Injection Is A Nucleotide Metabolic Inhibitor Indicated For: The Treatment Of Adult Patients With B-Cell Chronic Lymphocytic Leukemia (Cll) Who Have Not Responded To Or Whose Disease Has Progressed During Treatment With At Least One Standard Alkylating-Agent Containing Regimen. Benefit In Treatment-Naïve Or Non-Refractory Cll Patients Is Not Established. (1.1) 1.1 Indication Fludarabine Phosphate Injection Is Indicated For The Treatment Of Adult Patients With B-Cell Chronic Lymphocytic Leukemia (Cll) Who Have Not Responded To Or Whose Disease Has Progressed During Treatment With At Least One Standard Alkylating-Agent Containing Regimen. The Safety And Effectiveness Of Fludarabine Phosphate Injection In Previously Untreated Or Non-Refractory Patients With Cll Have Not Been Established. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
Name | Structure | ZINC ID(s) |
---|---|---|
1. Fludarabine Phosphate |
|
ZINC3927870 |